Jeżeli nie znalazłeś poszukiwanej książki, skontaktuj się z nami wypełniając formularz kontaktowy.

Ta strona używa plików cookies, by ułatwić korzystanie z serwisu. Mogą Państwo określić warunki przechowywania lub dostępu do plików cookies w swojej przeglądarce zgodnie z polityką prywatności.

Wydawcy

Literatura do programów

Informacje szczegółowe o książce

Radiopharmaceuticals for Positron Emission Tomography, Volume 1 - ISBN 9780470588956

Radiopharmaceuticals for Positron Emission Tomography, Volume 1

ISBN 9780470588956

Autor: Peter J. H. Scott, Brian G. Hockley, Michael R. Kilbourn

Wydawca: Wiley

Dostępność: 3-6 tygodni

Cena: 636,30 zł

Przed złożeniem zamówienia prosimy o kontakt mailowy celem potwierdzenia ceny.


ISBN13:      

9780470588956

ISBN10:      

0470588950

Autor:      

Peter J. H. Scott, Brian G. Hockley, Michael R. Kilbourn

Oprawa:      

Hardback

Rok Wydania:      

2012-03-27

Ilość stron:      

368

Wymiary:      

234x156

Tematy:      

MJ

The ultimate reference guide to the synthesis ofradiopharmaceuticals

The Radiochemical Syntheses series provides scientistsand professionals with a comprehensive reference to provensynthetic methods for radiochemical reactions, along withstep–by–step guidance on how to replicate these syntheses in thelaboratory.

Volume 1 in the series focuses on the synthesis and purificationof radiopharmaceuticals in clinical use today. It brings togetherin one complete, self–contained volume a collection of monographscontaining a wealth of practical information from across theliterature, demonstrating in meticulous detail how to prepareradiopharmaceuticals for positron emission tomography (PET)imaging, especially in tumor studies, cardiology, andneuroscience.

Readers have key experimental details culled from the literatureat their fingertips, greatly simplifying the process of qualifyinga site for the clinical production of new radiopharmaceuticals.



Contributors ix

Foreword xvii

Preface xix

Abbreviations xxi

Part 1: Fluorine–18 Labeled Radiopharmaceuticals 1

Chapter 1: Synthesis of [18F]Fluorodeoxyglucose([18F]FDG) 3
Michelle Richards and Peter J. H. Scott

Chapter 2: Synthesis of [18F]Sodium Fluoride([18F]NaF) 15
Brian Hockley and Peter J. H. Scott

Chapter 3: Radiosynthesis of3′–Deoxy–3′–[18F]Fluorothymidine ([18F]FLT)21
Hartmuth C. Kolb, Henry Padgett, Steve Zigler, Jim Patanella,Fanrong Mu, Umesh Gangadharmath, Vani P. Mocharla, Peter J. H.Scott and Joseph C. Walsh

Chapter 4: Synthesis of [18F]Fluoroazomycinarabinoside (18F–FAZA) 31
Brian G. Hockley and Peter J. H. Scott

Chapter 5: Synthesis of [18F]Fluoromisonidazole(1–(2–Hydroxy–3–[18F]fluoropropyl)–2–nitroimidazole,[18F]FMISO) 41
Patrick J. Riss, Valentina Ferrari, Robbie Bielik, RobertoCanales–Candela, Rob Smith, and Franklin I. Aigbirhio

Chapter 6: Synthesis of [18F]FPPRGD2 51
Shuanglong Liu, Frederick T. Chin, Zhen Cheng and XiaoyuanChen

Chapter 7: Synthesis of [18F]Fluorocholine([18F]FCH) 61
David Kryza

Chapter 8: Clinical Manufacturing of[18F]–16–a–Fluoroestradiol ([18F]FES)69
Piyush Kumar and John R. Mercer

Chapter 9: Synthesis of N–Succinimidyl4–[18F]Fluorobenzoate ([18F]SFB) 81
Xia Shao

Chapter 10: synthesis of4–(2´–Methoxyphenyl)–1–[2′–(N–2′′–pyridinyl)–p–[18F]fluorobenzamido]ethylpiperazine([18F]MPPF) 87
Marion Alvarez and Didier Le Bars

Chapter 11: Synthesis of [18F]Fallypride 95
Laurent Brichard, Valentina Ferrari, Rob Smith, and Franklin I.Aigbirhio

Chapter 12: Synthesis of [18F]Fluoroethyltyrosine([18F]FET) 103
Y. Zhao, A. Alfteimi and M. Zuhayra

Chapter 13: Synthesis of [18F]Flumazenil([18F]FZ) 111
Ralf Schirrmacher, Alexey Kostikov, Gassan Massaweh, MiriamKovacevic, Carmen Wängler, Alexander Thiel

Chapter 14: Synthesis of 6–[18F]Fluorodopamine(6–[18F]FDA) 125
Michael A. Channing, John L. Musachio, and Jozef J.Kusmierz

Chapter 15: Synthesis of2–([18F]fluoro)–3–[(2S)–2–Azetidinylmethoxy]Pyridine([18F]2FA) 139
Hayden T. Ravert, Daniel P. Holt and Robert F. Dannals

Chapter 16: Synthesis of [18F]–Substance–PAntagonist–receptor Quantifier ([18F]SPA–RQ) 155
Sofie Celen, Kim Serdons, Tjibbe de Groot, Terence G. Hamill,and Guy Bormans

Part 2: Carbon–11 Labeled Radiopharmaceuticals 167

Chapter 17: SYNTHESIS OF [11C]–Choline Chloride([11C]CHL) 169
Brian G. Hockley, Bradford Henderson and Xia Shao

Chapter 18: Synthesis of2–(4–N–[11C]methylaminophenyl)–6–hydroxybenzothiazole([11C]6–OH–BTA–1; [11C]PIB) 177
Cécile Philippe, Markus Mitterhauser andWolfgang Wadsak

Chapter 19: Synthesis of [11C]–Meta–hydroxyephedrine([11C]MHED) 191
Filippo Lodi, Assunta Carpinelli, Claudio Malizia and StefanoBoschi

Chapter 20: Synthesis ofL–[methyl–11C]Methionine([11C]MET) 199
Amy L. Vavere and Scott E. Snyder

Chapter 21: Synthesis of(+)– –[11C]–Dihydrotetrabenazine([11C]DTBZ) 213
Michael R. Kilbourn

Chapter 22: Synthesis of[11C]Flumazenil([11C]FMZ) 221
Roberto Canales–Candela, Patrick J. Riss and Franklin I.Aigbirhio

Chapter 23: Synthesis of [11C]–Hexadecanoic Acid([11C]Palmitic Acid) 233
Adam C. Runkle, Xia Shao and Peter J. H. Scott

Chapter 24: Synthesis of[O–Methyl–11C]Metomidate ([11C]MTO)245
István. Boros and Franklin I. Aigbirhio

Chapter 25: Synthesis of [11C]Carfentanil([11C]CFN) 257
Louis Tluczek and Xia Shao

Chapter 26: Synthesis of[carbonyl–11C]WAY–100635 265
J. D. Andersson, S. Nag, R. Krasikova, V.W. Pike and C.Halldin

Chapter 27: Synthesis of [11C]Raclopride 275
Xia Shao

Chapter 28: Synthesis of3–Amino–4–[2–(N–Methyl–N–[11C]Methyl–Amino–Methyl)Phenylsulfanyl]–Benzonitrile([11C]DASB) 285
Daniela Haeusler, Markus Mitterhauser andWolfgang Wadsak

Chapter 29: Synthesis of [11C]Acetate 297
Filippo Lodi, Claudio Malizia and Stefano Boschi

Chapter 30: Synthesis ofN–(2–[11C]Methoxybenzyl)–N–(4–Phenoxypyridin–3–yl)Acetamide([11C]PBR28) 305
Qi–Huang Zheng, Min Wang and Bruce H. Mock

Part 3: Other Radiopharmaceuticals 313

Chapter 31: Synthesis of [13N]Ammonia([13N]NH3) 315
Peter J. H. Scott

Chapter 32: Synthesis of [68Ga]GalliumDOTA–(TYR3)–Octreotide Acetate ([68Ga]DOTATOC) 321
Harald Eidherr, Friedrich Girschele, Markus Mitterhauser andWolfgang Wadsak

Appendix 1: Supplier Information 335

Index 339



Peter J. H. Scott is an Assistant Professor in theDepartment of Radiology at the University of Michigan MedicalSchool. Dr. Scott edited Linker Strategies in Solid–phaseOrganic Synthesis (also from Wiley) and is the series editorfor the Wiley Series on Solid Phase Organic Syntheses.

Brian G. Hockley is Radiopharmaceutical Quality Managerat the University of Michigan Medical School, where he works withMichael Kilbourn on radiopharmaceutical research and development.Mr. Hockley has co–authored several articles and a chapter inLinker Strategies in Solid–phase Organic Synthesis (alsofrom Wiley).

Koszyk

Książek w koszyku: 0 szt.

Wartość zakupów: 0,00 zł

ebooks
covid

Kontakt

Gambit
Centrum Oprogramowania
i Szkoleń Sp. z o.o.

Al. Pokoju 29b/22-24

31-564 Kraków


Siedziba Księgarni

ul. Kordylewskiego 1

31-542 Kraków

+48 12 410 5991

+48 12 410 5987

+48 12 410 5989

Zobacz na mapie google

Wyślij e-mail

Subskrypcje

Administratorem danych osobowych jest firma Gambit COiS Sp. z o.o. Na podany adres będzie wysyłany wyłącznie biuletyn informacyjny.

Autoryzacja płatności

PayU

Informacje na temat autoryzacji płatności poprzez PayU.

PayU banki

© Copyright 2012: GAMBIT COiS Sp. z o.o. Wszelkie prawa zastrzeżone.

Projekt i wykonanie: Alchemia Studio Reklamy